Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lite Strategy, Inc.MEIP · Entity 7396 | Director | July 15, 2025 | July 18, 2025 |
| Trillium Therapeutics Inc.TRIL · Entity 133265 | Director | January 01, 2021 | January 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lite Strategy, Inc.
Report date July 15, 2025 · Filed July 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.07 · Expires 2035-07-15 | Direct | 20,000 |
Reported balance
After 2025-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-07-15 · Grant · Acquired 20,000 · Balance 20,000 F1: Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025. |
| Common StockSEC Table I · non-derivative | Direct | 500 |
Reported balance
Holding disclosure · report date 2025-07-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 500 |
Filing footnotes · ownership attribution and instrument terms
F1: Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025.
Trillium Therapeutics Inc.
Report date January 01, 2021 · Filed January 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.03 · Expires 2030-12-23 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-01 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: 50% of the options vested immediately upon grant and the remaining options vest in equal monthly installments over the following six months. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.93 · Expires 2024-03-06 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F3: The exercise price of these options is $18.90 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.79 USD. F2: 1/3 of the options vested immediately upon grant and the remaining options vest in equal annual installments over the following four years. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.45 · Expires 2030-11-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F4: Options vest in equal quarterly installments over the three years following the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.45 · Expires 2030-11-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F5: Options vest in full on February 28, 2021. |
| Deferred Share UnitSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F6: Each Deferred Share Unit ("DSU") represents a contingent right to receive one common share of the Issuer (or cash in lieu of fractional DSUs) upon the termination of the grantee's service with the Issuer. All DSUs are fully vested as of the date hereof. |
Filing footnotes · ownership attribution and instrument terms
F1: 50% of the options vested immediately upon grant and the remaining options vest in equal monthly installments over the following six months.
F2: 1/3 of the options vested immediately upon grant and the remaining options vest in equal annual installments over the following four years.
F3: The exercise price of these options is $18.90 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.79 USD.
F4: Options vest in equal quarterly installments over the three years following the grant date.
F5: Options vest in full on February 28, 2021.
F6: Each Deferred Share Unit ("DSU") represents a contingent right to receive one common share of the Issuer (or cash in lieu of fractional DSUs) upon the termination of the grantee's service with the Issuer. All DSUs are fully vested as of the date hereof.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2025 Filed Jul 18, 2025 01:39 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0000929638-25-002638 · form4.xml · derivative · entry 2 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2035-07-15 F1 · security: Customary annual grant to non-employee directors of options to purchase shares of common stock was not made during the fiscal year ended June 30, 2025. Read SEC document |
| September 29, 2023 Filed Oct 12, 2023 23:40 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000929638-23-002769 · form4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-09-29 F1 · derivative.exercise_date: Such option shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning October 1, 2023 and continuing on the first day of each calendar month following such date and continuing through July 1, 2024. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 20:22 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 87,500 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0000899243-22-025700 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2032-07-05 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 23:02 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-21-045663 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:25 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018616 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 17:57 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | PurchaseCommon Stock | 10,000 | $1.60 | $16,000.00 |
DisclosureSEC source: 0001209191-19-061475 · doc4.xml · nonDerivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:33 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040980 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:28 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042673 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:34 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantOption to purchase shares of common stock · Derivative | 40,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044531 · doc4.xml · derivative · entry 1 Reynolds Thomas C · CIK 0001393945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,049 Underlying: Common Stock par value $0.00000002 · 40,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.